Skip to content
Home/Companies/Healthcare / Medtech/Advanced Perfusion Diagnostics

Advanced Perfusion Diagnostics

Healthcare / Medtech·France·Exited 2019·Held 7yr
Entry
2012
Hold
7yr
Exit
2019

Who owns Advanced Perfusion Diagnostics?

Advanced Perfusion Diagnostics was owned by Sofinnova Partners through Sofinnova Capital VII (2012 vintage) from 2012 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VII · 2012 · Life Sciences VC

Key facts

HQFrance
SectorHealthcare / Medtech
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from Sofinnova Capital VII

Other portfolio companies in the same fund.

Pixium Vision
Active
MedTechFrance· 2013
Ascendis Pharma
Exited 2015
BiotechDenmark· 2012
EOS
Exited 2013
BiotechItaly· 2012
to
GlycoVaxyn
Exited 2015
BiotechSwitzerland· 2012
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Advanced Perfusion Diagnostics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Advanced Perfusion Diagnostics?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Advanced Perfusion Diagnostics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue